Fundviser Capital shifts Rs 23 crore proceeds to Dubai unit

Fundviser Capital (India) Limited shifted Rs 23 crore of its Rs 79.44125 crore convertible-warrant issue allocation to Dubai-based subsidiary Silver Sage Trading by 30 September 2026, with no utilisation reported for that line item at the reporting date. Shareholders approved the revised allocations at the 41st annual general meeting on 22 September 2026.

Why did Fundviser Capital revise the warrant-proceeds allocation?

Fundviser Capital said the revised deployment of unutilised proceeds was approved by shareholders at its 41st annual general meeting on 22 September 2026. The original objects of the preferential issue included investments, long-term funding requirements, working capital and general corporate purposes to support the company’s future growth plan.

The preferential issue comprised 64,85,000 convertible warrants allotted on 25 November 2025 at Rs 122.50 each, including a Rs 10 face value and a Rs 112.50 premium. The stated aggregate issue amount was Rs 79.44125 crore, while the company initially received 25%, or Rs 19.8603125 crore, on the warrant allotment.

On 23 March 2026, Fundviser Capital converted 19,85,000 warrants into equity shares after receiving the remaining 75% amount of Rs 18.2371875 crore for those warrants. The company said 45,00,000 warrants remained outstanding after the conversion and that it raised no further amount from this issue during the quarter ended 30 September 2026.

Fundviser Capital reported Rs 3.3120295 crore as available for utilisation at 1 July 2026. It classified the September-quarter position as having no deviation or variation from the allocation altered by shareholders, rather than from the allocation originally attached to the warrant issue.

How did Fundviser Capital change allocations across subsidiaries?

Fundviser Capital reduced the revised allocation to DARS Transtrade Private Limited to Rs 13.7370295 crore from Rs 45 crore and cut Starlight Box Theatres Private Limited’s allocation to Rs 5.1509705 crore from Rs 12.50 crore. New India Re & Infra LLP’s allocation was unchanged at Rs 12.50 crore.

The company added Silver Sage Trading, described in the filing as its wholly owned foreign subsidiary in Dubai, United Arab Emirates, with a Rs 23 crore allocation where the original allocation had been nil. The allocation for investments, long-term funding requirements and ongoing business purposes rose to Rs 25.05325 crore from Rs 9.44125 crore.

The changes reduced the two named Indian subsidiary allocations by a combined Rs 38.612 crore: Rs 31.2629705 crore from DARS Transtrade and Rs 7.3490295 crore from Starlight Box Theatres. That amount matched the Rs 23 crore new Silver Sage Trading line and the Rs 15.612 crore increase in the general investments and funding category.

The revised allocation total remained Rs 79.44125 crore, unchanged from the stated aggregate amount of the 64,85,000-warrant issue. The filing records shareholder approval for every revised object on 22 September 2026 and records nil quarterly deviation against those revised amounts.

How much had Fundviser Capital used by 30 September 2026?

Fundviser Capital reported total utilisation of Rs 38.0975 crore by 30 September 2026 against the Rs 79.44125 crore revised allocation. The full revised amounts assigned to DARS Transtrade and Starlight Box Theatres, Rs 13.7370295 crore and Rs 5.1509705 crore respectively, had been utilised by that date.

New India Re & Infra had received Rs 8.90 crore from its unchanged Rs 12.50 crore allocation, leaving Rs 3.60 crore unutilised within that listed category. The company reported Rs 10.3095 crore used for investments, long-term funding requirements and ongoing business purposes from that category’s revised Rs 25.05325 crore allocation.

Silver Sage Trading had used none of its Rs 23 crore allocation as at 30 September 2026. The filing also shows Rs 14.74375 crore unutilised in the general investments and funding category, taking the unutilised amount across all listed allocations to Rs 41.34375 crore.

The utilisation pattern shows that the Dubai allocation had not been deployed at the reporting date, unlike the revised allocations for DARS Transtrade and Starlight Box Theatres. Fundviser Capital did not disclose a specific project, transaction or date for use of Silver Sage Trading’s Rs 23 crore allocation.

What governance review did Fundviser Capital disclose?

Fundviser Capital said its audit committee reviewed the deviation-or-variation statement at its meeting on 5 November 2026 and offered no comments. The filing also recorded nil auditor comments and said a monitoring agency was not applicable to the preferential issue.

The company reported no deviation or variation for the quarter ended 30 September 2026 because use of funds followed the allocation approved by shareholders at the 22 September 2026 meeting. Its disclosure treats the shareholder-approved revisions as the relevant benchmark for the quarterly statement.

Fundviser Capital’s filing defines deviation or variation as a change in the objects for which funds were raised, a difference between actual utilisation and originally disclosed utilisation, or a change in the terms of a fundraising contract. It recorded nil deviation for every revised object, including the Rs 23 crore Silver Sage Trading allocation.

Conclusion

Fundviser Capital materially changed the proposed deployment of its Rs 79.44125 crore warrant issue. The reallocation added Rs 23 crore for Silver Sage Trading and increased the general investments and funding category by Rs 15.612 crore, principally through reductions in the allocations to DARS Transtrade and Starlight Box Theatres.

The next disclosure to watch is whether Fundviser Capital starts using the Rs 23 crore allocated to Silver Sage Trading, which remained unutilised on 30 September 2026. The company also had 45,00,000 convertible warrants outstanding after the 23 March 2026 conversion, while its 5 November 2026 audit committee review recorded no comments on the revised-use statement.